GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Even One Pancreatic Duct Cannulation Raises PEP Risk-Endoscopy Feb.25

Even One Pancreatic Duct Cannulation Raises PEP Risk-Endoscopy Feb.25

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated February 1, 2026

Quick Answer

Introduction Post-ERCP pancreatitis (PEP) remains the most frequent and feared complication of ERCP. We all recognize that repeated pancreatic duct (PD) cannulations increase risk—but in real life, many cases involve just one inadvertent guidewire entry into the PD.


Introduction

Post-ERCP pancreatitis (PEP) remains the most frequent and feared complication of ERCP. We all recognize that repeated pancreatic duct (PD) cannulations increase risk—but in real life, many cases involve just one inadvertent guidewire entry into the PD. Until now, the clinical significance of a single PD cannulation has been debated, and practice varies: some teams escalate prophylaxis immediately, others don’t.

This study addresses a practical question every ERCPist faces:

Is a single inadvertent PD guidewire cannulation enough to meaningfully increase PEP risk?

Problem statement

Current thinking often focuses on “multiple cannulations” as the trigger for concern. But the true intraprocedural exposure—how often the PD is entered, how deep, and where the wire goes—has been poorly captured in routine datasets.

Key uncertainties:

  • Does one main PD cannulation matter?
  • Does location (head vs body vs side branch) change the risk?
  • Should a single PD cannulation trigger immediate prophylaxis escalation (e.g., PD stent)?

What they did (plain language)

  • Prospective, multicenter study across nine centers (biliary-indication ERCPs).
  • Real-time, third-party intraprocedural recording of PD wire entries (not just operator recall).
  • Standard 30-day follow-up for PEP outcomes.
  • Adjusted analysis accounting for other patient/procedure risk factors and prophylactic measures used.

Key findings clinicians should remember

1) A single main PD cannulation is independently linked to PEP

The key message: one inadvertent main PD cannulation is not “trivial.”

Risk increases with single cannulation and stays similarly elevated with multiple cannulations—meaning the “first hit” may account for much of the risk signal.

2) Where the wire goes matters

  • Main duct cannulation into the head and body was associated with higher PEP risk.
  • Side-branch only cannulations did not show a clear association.

3) Clinical implication: prophylaxis should be triggered earlier

Because one main PD cannulation already confers meaningful risk, this study supports a proactive stance:

  • If you inadvertently cannulate the main PD, treat it as a significant event—not a near-miss.

Practical “what should I do tomorrow?”

When to escalate prophylaxis (based on this study’s signal)

  • Any inadvertent main PD wire cannulation (even once), especially if it tracks into the head/body

→ strongly consider PD stent + standard prophylaxis bundle per your protocol.

When risk may be lower (but still use judgment)

  • Side-branch-only cannulation without main duct entry

→ may not carry the same risk signal, but consider the full clinical context.

Conclusion

This real-time multicenter dataset suggests that PEP risk starts with the first inadvertent main PD cannulation, and that the classic “multiple cannulations” framework may underestimate risk from a single wire entry. These findings support early use of preventive interventions—particularly PD stenting—when the main pancreatic duct is inadvertently cannulated.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer